يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"M. Wilbaux"', وقت الاستعلام: 1.61s تنقيح النتائج
  1. 1
    A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration‐Resistant Prostate Cancer

    المؤلفون: Benoit You, M. Wilbaux, Gilles Freyer, David Lorente, Michel Tod, J.S. de Bono, Joaquin Mateo, Emilie Henin

    المصدر: CPT: Pharmacometrics & Systems Pharmacology

    مصطلحات موضوعية: Oncology, Chemotherapy, medicine.medical_specialty, business.industry, Surrogate endpoint, medicine.medical_treatment, Original Articles, Castration resistant, medicine.disease, Bioinformatics, Treatment efficacy, Prostate cancer, Circulating tumor cell, Antigen, Modeling and Simulation, Internal medicine, Medicine, Pharmacology (medical), In patient, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4085eb1155bc121dd79dac43bb034c69Test
    https://doi.org/10.1002/psp4.34Test


    أضف إلى المفضلة
  2. 2
    Prédiction de la résistance à la chimiothérapie des tumeurs trophoblastiques gestationnelles (TTG) de bas risque par l’analyse de la cinétique des hCG

    المؤلفون: M. Wilbaux, Emilie Henin, Jérôme Massardier, Michel Tod, Benoit You, Gilles Freyer, François Golfier, Olivier Colomban, Touria Hajri

    المصدر: Oncologie. 16:300-305

    مصطلحات موضوعية: Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a64685edfef3ff3cd854d64ea21f2693Test
    https://doi.org/10.1007/s10269-014-2408-9Test


    أضف إلى المفضلة
  3. 3
    Dynamic modeling in ovarian cancer: An original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development

    المؤلفون: Benoit You, Gilles Freyer, Eric Pujade-Lauraine, Olivier Colomban, Emilie Henin, M. Wilbaux, Amit M. Oza, Michel Tod

    المصدر: Gynecologic Oncology. 133:460-466

    مصطلحات موضوعية: Adult, Oncology, medicine.medical_specialty, Paclitaxel, Disease-Free Survival, Carboplatin, Polyethylene Glycols, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Drug Discovery, Biomarkers, Tumor, medicine, Humans, Progression-free survival, Survival analysis, Aged, Parametric statistics, Aged, 80 and over, Ovarian Neoplasms, Models, Statistical, Predictive marker, Tumor size, business.industry, Obstetrics and Gynecology, Middle Aged, medicine.disease, Surgery, System dynamics, Kinetics, Treatment Outcome, Drug development, Doxorubicin, CA-125 Antigen, Female, Neoplasm Recurrence, Local, Ovarian cancer, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ccc2bfc64e85a5daa3dbc3009a8c1f9Test
    https://doi.org/10.1016/j.ygyno.2014.04.003Test


    أضف إلى المفضلة
  4. 4
    Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients

    المؤلفون: Benoit You, Amit M. Oza, M. Wilbaux, Gilles Freyer, Michel Tod, Olivier Colomban, Eric Pujade-Lauraine, Emilie Henin

    المصدر: British Journal of Cancer

    مصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Pathology, medicine.medical_treatment, ovarian epithelial cancer, Carcinoma, Ovarian Epithelial, Models, Biological, Disease-Free Survival, Carboplatin, Polyethylene Glycols, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Humans, Doxorubicin, mathematical modelling, Neoplasms, Glandular and Epithelial, K–PD modelling, Aged, Aged, 80 and over, Ovarian Neoplasms, Chemotherapy, business.industry, CA-125 kinetics, Membrane Proteins, Middle Aged, Prognosis, medicine.disease, Clinical trial, Data set, chemistry, CA-125 Antigen, Biomarker (medicine), Female, Neoplasm Recurrence, Local, Translational Therapeutics, business, tumour size prediction, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0fe9faf1f61ddec6306711067920f03Test
    https://doi.org/10.1038/bjc.2014.75Test


    أضف إلى المفضلة
  5. 5
    Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements

    المؤلفون: M. Wilbaux, Emilie Henin, Richard A. Harvey, Benoit You, Gilles Freyer, Philip Savage, François Golfier, Michel Tod, H. Mitchell, Michael J. Seckl

    المصدر: British Journal of Cancer

    مصطلحات موضوعية: Adult, Antimetabolites, Antineoplastic, Cancer Research, medicine.medical_specialty, Population, Urology, Drug resistance, Chorionic Gonadotropin, methotrexate, Pregnancy, Internal medicine, Biomarkers, Tumor, gestational trophoblastic neoplasia, medicine, Humans, Treatment Failure, Gestational Trophoblastic Disease, education, Molecular Diagnostics, education.field_of_study, drug resistance, Predictive marker, decision support techniques, business.industry, Gestational trophoblastic disease, Area under the curve, medicine.disease, Endocrinology, ROC Curve, Oncology, Drug Resistance, Neoplasm, Multivariate Analysis, Cohort, Female, Methotrexate, prognosis, Gestational trophoblastic neoplasia, business, neoplasm, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e504c296915f74d29c47b3d59654c9Test
    https://doi.org/10.1038/bjc.2013.123Test


    أضف إلى المفضلة
  6. 6
    A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment

    المؤلفون: Amit M. Oza, Gilles Freyer, M. Wilbaux, R. Almufti, Michel Tod, Benoit You, Olivier Colomban, Emilie Henin

    المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 25(1)

    مصطلحات موضوعية: Adenoma, Male, business.industry, Kinetics, Prostatic Neoplasms, Hematology, Bioinformatics, Models, Biological, Treatment efficacy, Tumor Biomarkers, Circulating tumor cell, Oncology, Anticancer treatment, Serum biomarkers, Area Under Curve, Biomarkers, Tumor, Biomarker (medicine), Medicine, Humans, Time point, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::141ac24aa196f56d09386a1df92b6b9aTest
    https://pubmed.ncbi.nlm.nih.gov/24356619Test


    أضف إلى المفضلة
  7. 7
    Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen Increases

    المؤلفون: Gilles Freyer, Olivier Colomban, Félicité de Charry, Michel Tod, Paul Perrin, Philippe Paparel, Alain Ruffion, Benoit You, M. Wilbaux

    المساهمون: Ciblage thérapeutique en Oncologie (EA3738), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, Institut de Génomique Fonctionnelle de Lyon (IGFL), École normale supérieure - Lyon (ENS Lyon)-Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Applications des ultrasons à la thérapie, Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Oncologie Médicale [Centre hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Ciblage thérapeutique en Oncologie ( EA3738 ), Université Claude Bernard Lyon 1 ( UCBL ), Institut de Génomique Fonctionnelle de Lyon ( IGFL ), École normale supérieure - Lyon ( ENS Lyon ) -Institut National de la Recherche Agronomique ( INRA ) -Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique ( CNRS ), Centre de Recherche en Cancérologie de Lyon ( CRCL ), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Centre Hospitalier Lyon Sud [CHU - HCL] ( CHLS ), Hospices Civils de Lyon ( HCL ) -Hospices Civils de Lyon ( HCL ), Hospices Civils de Lyon ( HCL ), École normale supérieure de Lyon (ENS de Lyon)-Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL)

    المصدر: Clinical Genitourinary Cancer
    Clinical Genitourinary Cancer, Elsevier, 2016, 14 (3), pp.210-217. ⟨10.1016/j.clgc.2015.12.006⟩
    Clinical Genitourinary Cancer, Elsevier, 2016, 14 (3), pp.210-217. 〈10.1016/j.clgc.2015.12.006〉
    Clinical Genitourinary Cancer, 2016, 14 (3), pp.210-217. ⟨10.1016/j.clgc.2015.12.006⟩

    مصطلحات موضوعية: Male, Pathology, Survival, analysis, medicine.medical_treatment, 030232 urology & nephrology, Kaplan-Meier Estimate, Growth, urologic and male genital diseases, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, surgery, Prostate cancer, 0302 clinical medicine, Odds Ratio, Univariate analysis, Prostatectomy, Hazard ratio, Prostate, Middle Aged, Tumor Burden, 3. Good health, Prostate-specific antigen, Oncology, 030220 oncology & carcinogenesis, Regression Analysis, Kallikreins, France, PCA3, medicine.medical_specialty, Patients, Cells, Urology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Risk Assessment, Disease-Free Survival, methods, Time, 03 medical and health sciences, medicine, Humans, Aged, Proportional Hazards Models, Retrospective Studies, Hyperplasia, business.industry, Carcinoma, Prostatic Neoplasms, Odds ratio, Prostate-Specific Antigen, medicine.disease, Confidence interval, Kinetics, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6e14ac420d04a618307379865b5e05Test
    https://doi.org/10.1016/j.clgc.2015.12.006Test


    أضف إلى المفضلة
  8. 8
    Validation of Modeled Early Longitudinal Ca-125 Kinetics for Predicting Survival in Ovarian Cancer (Oc) Phase III Trials: Could the Failure of Adding Gemcitabine to Carboplatin-Paclitaxel (Ago-Ovar 9) Have Been Foreseen Earlier in the Trial?

    المؤلفون: A-C. Hardy-Bessard, A. du Bois, M. Wilbaux, Alain Lortholary, Jacobus Pfisterer, Gilles Freyer, Eric Pujade-Lauraine, Michel Tod, Emilie Henin, Alexander Reuss, Benoit You, Jalid Sehouli, Uwe Wagner

    المصدر: Annals of Oncology. 25:iv63

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, education.field_of_study, Chemotherapy, business.industry, medicine.medical_treatment, Population, Hematology, Chemotherapy regimen, Carboplatin, Gemcitabine, chemistry.chemical_compound, chemistry, Internal medicine, medicine, Topotecan, education, business, Survival analysis, Epirubicin, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::40732e1e1b15dd78d4e99be30092b6a3Test
    https://doi.org/10.1093/annonc/mdu326.15Test


    أضف إلى المفضلة
  9. 9
    Benefit in progression-free survival (PFS) to expect based on CA125 reduction at week 6 in recurrent ovarian cancer (ROC) patients: CALYPSO phase III trial data (a GINECO-GCIG study)

    المؤلفون: Amit M. Oza, Benoit You, Gilles Freyer, M. Wilbaux, Olivier Colomban, Emilie Henin, Michel Tod, Eric Pujade-Lauraine

    المصدر: Journal of Clinical Oncology. 31:5547-5547

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, endocrine system diseases, business.industry, medicine.medical_treatment, Surgery, Survival benefit, Recurrent Ovarian Cancer, Internal medicine, medicine, Progression-free survival, business, Reduction (orthopedic surgery), Selection (genetic algorithm)

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c00579cbd05736339af635e40e6f0982Test
    https://doi.org/10.1200/jco.2013.31.15_suppl.5547Test


    أضف إلى المفضلة
  10. 10
    Confirmation of the Prognostic Value of Modeled PSA Clearance after Radical Prostatectomy: Results of the Validation PSAMODEL Study

    المؤلفون: Emilie Henin, Benoit You, Alain Ruffion, Gilles Freyer, M. Wilbaux, Denis Maillet, Paul Perrin, Michel Tod

    المصدر: Annals of Oncology. 23:ix299

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Multivariate statistics, Multivariate analysis, Prostatectomy, business.industry, Proportional hazards model, medicine.medical_treatment, Univariate, Hematology, medicine.disease, NONMEM, Prostate cancer, medicine.anatomical_structure, Prostate, Internal medicine, medicine, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4e8f1049a778beb6b765ed3c537567a7Test
    https://doi.org/10.1016/s0923-7534Test(20)33464-5


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث